News
A class action lawsuit was filed against Merck & Co. (MRK) by Levi & Korsinsky on February 12, 2025. The plaintiffs (shareholders) alleged that they bought MRK stock at artificially inflated ...
4d
News-Medical.Net on MSNAdvancing Adherent Cell Assays with SemaCyte® TechnologySemarion's SemaCyte® technology transforms adherent cell assays, enabling faster, automated workflows that enhance ...
Pharmacovigilance evolves with technology, employing active surveillance to detect drug-related issues and ensure safety in ...
During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.
Opinion: Omnus Law's Judy Yen says Duke University's ire over a T-shirt worn in "The White Lotus" shows why intellectual ...
President Donald Trump announced a 90-day pause on all tariffs except for those against China, which he said would now rise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results